FDA Inspection 1068751 — Sarah Mangles, MD
The FDA completed an inspection of Sarah Mangles, MD on Sep 14, 2018 in Basingstoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Basingstoke (United Kingdom)
Additional Details
Clinical Investigator (CI)